Insurers and hospitals want the CMS to amend its proposed rule eliminating the safe harbor for Medicare Part D and Medicaid managed-care drug rebates to include new requirements for drugmakers.
保險公司和醫院希望CMS修改其擬議規則，取消Medicare D部分和醫療補助管理醫療藥品退稅的保護條例，以及加入對製藥商的新要求。
The new rule would create a system "in which transparent, upfront discounts benefit patients, rather than a system driven by rebates that may not be used to directly benefit patients using the medicines for which the rebate is paid"
新規則將創建一個”透明系統"，使患者受益的前期折扣系統，而不是透過回扣的系統，因回扣系統可能不會直接讓使用藥物的患者受益
若您有更多關於健康保險的相關問題，歡迎諮詢！ If you have more question about health insurance, feel free to contact us!
電話 Phone: 626-912-1988 Email: 1234@ppo-hmo.com
Comments